Defunct Company
Total Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
528
NCT02888756
iHIVARNA Clinical Trial in HIV Infected Individuals
Phase: Phase 2
Role: Collaborator
Start: Apr 4, 2017
Completion: Feb 12, 2018
NCT05303402
A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.
Phase: Phase 2/3
Start: May 12, 2022
Completion: Dec 1, 2023
NCT06234956
Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.
Start: Jun 8, 2023
Completion: Sep 9, 2025
NCT06170138
Study to Assess PK, PD, Nicotine Extraction, Palatability, Subjective Effects of Nicotine Pouches - Daily Nicotine Users
Phase: N/A
Role: Lead Sponsor
Start: Nov 24, 2023
Completion: Mar 31, 2024